Compare MYGN & CWCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYGN | CWCO |
|---|---|---|
| Founded | 1991 | 1973 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.5M | 554.4M |
| IPO Year | 1995 | N/A |
| Metric | MYGN | CWCO |
|---|---|---|
| Price | $7.17 | $34.07 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 1 |
| Target Price | $12.58 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 1.1M | 94.5K |
| Earning Date | 11-03-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 1.64% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.05 |
| Revenue | ★ $825,300,000.00 | $130,832,698.00 |
| Revenue This Year | $0.10 | $4.65 |
| Revenue Next Year | $5.28 | $52.38 |
| P/E Ratio | ★ N/A | $31.58 |
| Revenue Growth | ★ 0.21 | N/A |
| 52 Week Low | $3.76 | $22.69 |
| 52 Week High | $16.63 | $38.36 |
| Indicator | MYGN | CWCO |
|---|---|---|
| Relative Strength Index (RSI) | 47.96 | 46.67 |
| Support Level | $6.93 | $33.28 |
| Resistance Level | $7.38 | $34.48 |
| Average True Range (ATR) | 0.39 | 0.88 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 39.88 | 33.89 |
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.